Free Trial

Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY) Sees Significant Increase in Short Interest

Daiichi Sankyo logo with Medical background

Key Points

  • Daiichi Sankyo Co., Ltd. experienced a substantial increase in short interest in July, rising by 2,442.5% from 4,000 to 101,700 shares.
  • The company's stock price rose by 0.8%, reaching $24.54, with a market capitalization of $46.49 billion and a P/E ratio of 23.83.
  • Nomura Securities upgraded Daiichi Sankyo to a "strong-buy" rating, indicating positive sentiment towards the stock's future performance.
  • Want stock alerts on Daiichi Sankyo? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report) was the target of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 101,700 shares, agrowthof2,442.5% from the July 15th total of 4,000 shares. Based on an average daily volume of 460,100 shares, the short-interest ratio is currently 0.2 days. Approximately0.0% of the shares of the company are sold short. Approximately0.0% of the shares of the company are sold short. Based on an average daily volume of 460,100 shares, the short-interest ratio is currently 0.2 days.

Daiichi Sankyo Trading Up 0.8%

Shares of DSNKY traded up $0.19 during mid-day trading on Thursday, reaching $24.54. 140,912 shares of the company's stock traded hands, compared to its average volume of 255,615. The stock has a market cap of $46.49 billion and a P/E ratio of 23.83. Daiichi Sankyo has a 12 month low of $20.92 and a 12 month high of $42.48. The stock's 50-day moving average is $23.74 and its two-hundred day moving average is $24.25. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.53 and a quick ratio of 1.85.

Analyst Upgrades and Downgrades

Separately, Nomura Securities raised Daiichi Sankyo to a "strong-buy" rating in a report on Friday, June 6th.

Get Our Latest Stock Analysis on DSNKY

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Daiichi Sankyo Right Now?

Before you consider Daiichi Sankyo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.

While Daiichi Sankyo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines